Voyager Therapeutics, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | -$0.44 | -$0.44 | -$0.44 |
Q2 2024 | 2 | -$0.41 | -$0.41 | -$0.41 |
Q3 2024 | 7 | -$0.61 | -$0.29 | -$0.49 |
Q4 2024 | 2 | -$0.51 | -$0.51 | -$0.51 |
Q1 2025 | 3 | -$0.56 | -$0.56 | -$0.56 |
Q2 2025 | 3 | -$0.46 | -$0.46 | -$0.46 |
Q3 2025 | 6 | -$0.45 | -$0.45 | -$0.45 |
Q4 2025 | 5 | -$0.58 | -$0.58 | -$0.58 |
Q1 2026 | 4 | -$0.57 | -$0.57 | -$0.57 |
Q2 2026 | 3 | -$0.57 | -$0.57 | -$0.57 |
Q3 2026 | 2 | -$0.61 | -$0.61 | -$0.61 |
Q4 2026 | 2 | -$0.61 | -$0.61 | -$0.61 |
Voyager Therapeutics, Inc. Earnings Date And Information
Voyager Therapeutics, Inc. last posted its earnings results on Tuesday, August 6th, 2024. The company reported $-0.18 earnings per share for the quarter, topping analysts' consensus estimates of $-0.38 by $0.2. The company had revenue of 29.58 M for the quarter and had revenue of 250.01 M for the year. Voyager Therapeutics, Inc. has generated $3 earnings per share over the last year ($2.97 diluted earnings per share) and currently has a price-to-earnings ratio of 37.3. Voyager Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based on prior year's report dates.
Voyager Therapeutics, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/06/2024 | Q2 2024 | -$0.38 | -$0.18 | 0.2 | $9.51 M | $29.58 M |
05/13/2024 | Q1 2024 | -$0.44 | -$0.20 | 0.24 | $19.52 M | |
12/30/2023 | Q4 2023 | $1.28 | $90.06 M | |||
11/06/2023 | Q3 2023 | -$0.58 | -$0.59 | -0.01 | $2.91 M | $4.61 M |
08/03/2023 | Q2 2023 | -$0.59 | -$0.51 | 0.08 | $1.60 M | $4.85 M |
05/09/2023 | Q1 2023 | $0.77 | $3.05 | 2.28 | $150.48 M | |
03/07/2023 | Q4 2022 | -$0.57 | -$0.61 | -0.04 | $-41,087,000 | |
11/08/2022 | Q3 2022 | -$0.32 | $0.46 | 0.78 | $9.42 M | $41.09 M |
08/04/2022 | Q2 2022 | -$0.56 | -$0.49 | 0.07 | $712,000 | |
05/04/2022 | Q1 2022 | -$0.14 | -$0.56 | -0.42 | $12.71 M | $658,000 |
03/08/2022 | Q4 2021 | -$0.32 | $0.15 | 0.47 | $4.30 M | $28.07 M |
11/02/2021 | Q3 2021 | -$0.75 | -$0.67 | 0.08 | $2.14 M | $1.48 M |
08/09/2021 | Q2 2021 | -$0.75 | -$0.80 | -0.05 | $4.18 M | $1.36 M |
05/10/2021 | Q1 2021 | -$0.71 | -$0.58 | 0.13 | $7.55 M | $6.50 M |
02/25/2021 | Q4 2020 | -$0.52 | -$0.43 | 0.09 | $16.59 M | $6.54 M |
11/09/2020 | Q3 2020 | -$0.19 | $2.30 | 2.49 | $15.05 M | $117.84 M |
08/10/2020 | Q2 2020 | -$0.75 | -$0.23 | 0.52 | $16.52 M | $28.68 M |
05/06/2020 | Q1 2020 | -$0.87 | -$0.66 | 0.21 | $13.55 M | $18.07 M |
03/03/2020 | Q4 2019 | -$0.81 | -$0.34 | 0.47 | $9.93 M | $32.67 M |
11/06/2019 | Q3 2019 | -$0.83 | -$0.41 | 0.42 | $6.88 M | $20.43 M |
Voyager Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Voyager Therapeutics, Inc.'s earnings date?
Voyager Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates.
-
Did Voyager Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Voyager Therapeutics, Inc. (:VYGR) reported $-0.18 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.38 by $0.2.
-
How can I listen to Voyager Therapeutics, Inc.'s earnings conference call?
The conference call for Voyager Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Voyager Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Voyager Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Voyager Therapeutics, Inc. generate each year?
Voyager Therapeutics, Inc. (:VYGR) has a recorded annual revenue of $250.01 M.
-
How much profit does Voyager Therapeutics, Inc. generate each year?
Voyager Therapeutics, Inc. (:VYGR) has a recorded net income of $250.01 M. Voyager Therapeutics, Inc. has generated $3.08 earnings per share over the last four quarters.
-
What is Voyager Therapeutics, Inc.'s price-to-earnings ratio?
Voyager Therapeutics, Inc. (:VYGR) has a price-to-earnings ratio of 37.3 and price/earnings-to-growth ratio is 0.11.